UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000047368 |
|---|---|
| Receipt number | R000053936 |
| Scientific Title | Immune Persistence and Safety Pediatric Survey (Aged 5-11 Years) related to the SARS-CoV-2 Vaccination (Primary series and Booster Vaccination) in Japan |
| Date of disclosure of the study information | 2022/04/02 |
| Last modified on | 2025/04/07 14:14:47 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2022/04/02 11:10:27 | ||
| 2 | Update | 2022/04/02 11:34:47 | Public title Acronym Scientific Title Scientific Title:Acronym |
|
| 3 | Update | 2022/04/02 11:39:25 | Name of primary person or sponsor Institute Institute |
|
| 4 | Update | 2022/04/02 11:42:40 | Name of primary person or sponsor Institute |
|
| 5 | Update | 2022/06/01 18:12:33 | Institutions |
|
| 6 | Update | 2022/08/06 15:25:16 | UMIN ID1 |
|
| 7 | Update | 2022/08/06 15:53:26 | Name of primary person or sponsor Institute Institutions |
|
| 8 | Update | 2022/08/06 15:55:57 | Division |
|
| 9 | Update | 2022/08/06 16:01:19 | Organization |
|
| 10 | Update | 2022/08/06 16:03:23 | Recruitment status Last follow-up date |
|
| 11 | Update | 2022/11/07 14:26:35 | Public title Public title Scientific Title Scientific Title |
|
| 12 | Update | 2022/11/07 14:32:19 | Organization Organization Division name Division name TEL Organization Organization Division name Division name TEL Institute Institute |
|
| 13 | Update | 2022/11/16 20:25:38 | Public title Scientific Title |
|
| 14 | Update | 2022/11/16 20:32:30 | Name of primary person or sponsor Institute Institute Department Organization |
|
| 15 | Update | 2023/05/18 09:32:01 | Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 16 | Update | 2023/05/18 09:33:40 | Department |
|
| 17 | Update | 2023/05/18 10:07:04 | Other related information Other related information |
|
| 18 | Update | 2023/09/19 14:25:23 | Key secondary outcomes |
|
| 19 | Update | 2023/09/19 14:48:29 | Key inclusion criteria Key inclusion criteria Target sample size |
|
| 20 | Update | 2023/09/19 15:11:44 | TEL Organization Organization Division name Division name TEL Institute Department Organization Organization Address1 Address Address |
|
| 21 | Update | 2023/09/19 15:12:26 | Publication of results |
|
| 22 | Update | 2023/09/19 15:16:25 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Other related information Other related information |
|
| 23 | Update | 2023/09/19 15:22:37 | Homepage URL |
|
| 24 | Update | 2023/09/19 15:37:51 | Name of primary person or sponsor Institute |
|
| 25 | Update | 2024/04/02 11:20:11 | Recruitment status |
|
| 26 | Update | 2024/04/03 14:36:42 | URL related to results and publications Number of participants that the trial has enrolled |
|
| 27 | Update | 2024/04/03 14:40:43 | Institutions |
|
| 28 | Update | 2025/04/07 14:14:47 | Recruitment status |
